CELLDEX Trademark

Trademark Overview


On Friday, August 28, 2015, a trademark application was filed for CELLDEX with the United States Patent and Trademark Office. The USPTO has given the CELLDEX trademark a serial number of 86740171. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Friday, November 3, 2023. This trademark is owned by CELLDEX THERAPEUTICS, INC.. The CELLDEX trademark is filed in the Pharmaceutical Products category with the following description:

[ Vaccines; Therapeutic vaccines; ] Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for immunotherapy treatment; [ Antibody drug conjugates, namely, pharmaceutical preparations for the treatment of cancer, and for the treatment of diseases of the integumentary system and reproductive system; ] Pharmaceutical preparations derived from monoclonal antibodies for the treatment of cancer, [ and for the treatment of diseases of the respiratory system, circulatory system, lymphatic system, nervous system, urinary system, digestive system, integumentary system and reproductive system; ] Therapeutic antibodies and immune system modulators, namely, pharmaceutical preparations for the treatment of cancer, [ and for the treatment of diseases of the respiratory system, circulatory system, lymphatic system, nervous system, urinary system, digestive system, integumentary system and reproductive system; Pharmaceutical preparations and substances for use as vaccine ...
celldex

General Information


Serial Number86740171
Word MarkCELLDEX
Filing DateFriday, August 28, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateFriday, November 3, 2023
Registration Number5076311
Registration DateTuesday, November 8, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 23, 2016

Trademark Statements


Goods and Services[ Vaccines; Therapeutic vaccines; ] Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for immunotherapy treatment; [ Antibody drug conjugates, namely, pharmaceutical preparations for the treatment of cancer, and for the treatment of diseases of the integumentary system and reproductive system; ] Pharmaceutical preparations derived from monoclonal antibodies for the treatment of cancer, [ and for the treatment of diseases of the respiratory system, circulatory system, lymphatic system, nervous system, urinary system, digestive system, integumentary system and reproductive system; ] Therapeutic antibodies and immune system modulators, namely, pharmaceutical preparations for the treatment of cancer, [ and for the treatment of diseases of the respiratory system, circulatory system, lymphatic system, nervous system, urinary system, digestive system, integumentary system and reproductive system; Pharmaceutical preparations and substances for use as vaccine adjuvants, growth factors, namely, ligands and proteins for stem cells in stem cell mobilization; ] pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely, [ immune system stimulators and ] immune system modulators

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 1, 2015
Primary Code005
First Use Anywhere DateMonday, April 13, 2009
First Use In Commerce DateMonday, April 13, 2009

Trademark Owner History


Party NameCELLDEX THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressHampton, NJ 08827

Party NameCELLDEX THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHampton, NJ 08827

Party NameCELLDEX THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHampton, NJ 08827

Trademark Events


Event DateEvent Description
Tuesday, September 1, 2015NEW APPLICATION ENTERED
Tuesday, September 1, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 11, 2015ASSIGNED TO EXAMINER
Saturday, December 19, 2015NON-FINAL ACTION WRITTEN
Saturday, December 19, 2015NON-FINAL ACTION E-MAILED
Saturday, December 19, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 20, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, June 20, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 21, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 15, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 3, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 23, 2016PUBLISHED FOR OPPOSITION
Tuesday, August 23, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 8, 2016REGISTERED-PRINCIPAL REGISTER
Monday, November 8, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, May 8, 2023TEAS SECTION 8 & 15 RECEIVED
Friday, November 3, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 3, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Friday, November 3, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, November 8, 2025COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED